Laboratory platform use case

Bioprocess monitoring

In companies involved with bioproduction, ELISA is used by R&D analytical and quality control teams to titer the active principle or detect contaminant (HCP). Depending on the organization, results are sometimes given only within 15 days. This impacts bioprocesses R&D or bioproduction efficiency, and in some cases, the release titer itself.

The MagIA diagnostics laboratory system can be implemented for

• Bioprocess development: Cut the duration of bioprocess development projects in which ELISA analysis may take up to 1/3 of the time.
• Bioproduction efficiency: Vaccine productions can be optimized in real time with reliable IPC to adjust production parameters. This avoids production line immobilisation & batch losses.